Dr. Xiaolin Hou is a distinguished researcher affiliated with Beijing University of Agriculture, specializing in veterinary virology, immunology, and nanobiotechnology applications in animal health. With a prolific portfolio of 58 publications and over 1,200 citations, Dr. Hou has significantly contributed to the understanding of viral pathogenesis and host immune modulation, particularly in chronic hepatitis B and porcine reproductive and respiratory syndrome virus. His research emphasizes innovative approaches to disease prevention and therapeutic interventions, including nanoparticle-mediated drug delivery, quantum dot polymer inhibitors, and advanced immunoassay techniques for mycotoxin detection. Collaborating extensively with a global network of 174 co-authors, Dr. Hou integrates multidisciplinary expertise across molecular biology, food safety, and pharmaceutical sciences to develop practical solutions for veterinary and public health challenges. His work demonstrates a consistent focus on enhancing immune responses, suppressing pathogenic mechanisms, and improving disease diagnostics, reflecting both academic rigor and societal impact. Notably, Dr. Hou’s research bridges fundamental science with applied technologies, fostering advancements in animal therapeutics, vaccine development, and food safety monitoring. Recognized for both methodological innovation and translational relevance, his contributions continue to shape contemporary approaches in veterinary pharmacology and virology research on an international scale.

Profiles: Scopus | ORCID